MedTrace Logo

SURE 18 Registry -Asahi Chikai Black 18 in LVO Stroke

NCT03438565 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2020-03-10

No results posted yet for this study

Summary

The objective of this study is to obtain post market data on the Asahi Chikai Black 18 neurovascular guidewire in the treatment of intracranial large vessel occlusive stroke. This will be compared to a historical control that will include the prior 50 consecutive patients fitting the same selection criteria.

Conditions

  • Occlusive Stroke

Interventions

DEVICE

Asahi Chikai Black 18 neurovascular guidewire

The Asahi Chikai Black 18 microguidewire employs a reverse tapered shaft with 0.018" tip and 0.014" proximal shaft, which provides additional support and tactile feedback.

Sponsors & Collaborators

Principal Investigators

  • Reade De Leacy, MD · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-18
Primary Completion
2020-02-01
Completion
2020-02-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03438565 on ClinicalTrials.gov